Predictors of outcome of reperfusion therapy.
暂无分享,去创建一个
K. Lee | R. Califf | C. Granger | E. M. Ohman | E. Ohman | K. Lee
[1] R. D'Agostino,et al. Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results. , 1994, Circulation.
[2] J Col,et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.
[3] G. Breithardt,et al. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. , 1991, European heart journal.
[4] R. Califf,et al. Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction , 1991 .
[5] R. Califf,et al. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. , 1989, Circulation.
[6] P. Kudenchuk,et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). , 1993, The American journal of cardiology.
[7] T. Killip,et al. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.
[8] U. Goldbourt,et al. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction , 1993 .
[9] David Hunt,et al. ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .
[10] P. Grande,et al. Estimation of Acute Myocardial Infarct Size in Man by Serum CK‐MB Measurements , 1982, Circulation.
[11] R. Reneman,et al. Complete recovery in plasma of enzymes lost from the heart after permanent coronary artery occlusion in the dog. , 1990, Circulation.
[12] K. Swedberg,et al. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. , 1995, European heart journal.
[13] H. Hod,et al. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. , 1990, British heart journal.
[14] E. Negri,et al. Determinants of 6‐Month Mortality in Survivors of Myocardial Infarction After Thrombolysis Results of the GISSI‐2 Data Base , 1993, Circulation.
[15] E. Braunwald,et al. Predictors of Early Morbidity and Mortality After Thrombolytic Therapy of Acute Myocardial Infarction: Analyses of Patient Subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase II , 1992, Circulation.
[16] R. Califf,et al. Racial Differences in Responses to Thrombolytic Therapy With Recombinant Tissue‐Type Plasminogen Activator: Increased Fibrin(ogen)olysis in Blacks , 1991, Circulation.
[17] E. Topol,et al. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. , 1988, American heart journal.
[18] C. Peterson. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: Grines CL, Browne KF, Marco J, et al. N Engl J Med 328:673–679 Mar 1993 , 1993 .
[19] K Wegscheider,et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.
[20] M. Pfisterer,et al. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. , 1996, European heart journal.
[21] J. Herlitz,et al. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. , 1994, European heart journal.
[22] J. Goldberg,et al. Psychosocial influences on mortality after myocardial infarction. , 1984, The New England journal of medicine.
[23] J E Keil,et al. Socioeconomic factors and cardiovascular disease: a review of the literature. , 1993, Circulation.
[24] M. Krucoff,et al. Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. , 1986, The American journal of cardiology.
[25] S. Chierchia,et al. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. , 1987, The New England journal of medicine.
[26] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.
[27] R B D'Agostino,et al. A Time-Insensitive Predictive Instrument for Acute Myocardial Infarction Mortality: A Multicenter Study , 1991, Medical care.
[28] R. Califf,et al. Outcome of Patients Sustaining Acute Ischemic Mitral Regurgitation during Myocardial Infarction , 1992, Annals of Internal Medicine.
[29] R. Califf,et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy , 1993, The Lancet.
[30] R. Califf,et al. Prognostic significance of isolated sinus tachycardia during first three days of acute myocardial infarction. , 1984, The American journal of medicine.
[31] R. Diaz,et al. Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial , 1993, Circulation.
[32] G. Tognoni,et al. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). , 1989, The American journal of cardiology.
[33] R. Ideker,et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. , 1984, Circulation.
[34] W. O’Neill,et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. , 1991, Annals of internal medicine.
[35] A. Maseri,et al. Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis , 1993 .
[36] P. Shah,et al. Angiographic validation of bedside markers of reperfusion. , 1993, Journal of the American College of Cardiology.
[37] B. McNeil,et al. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project. , 1996, JAMA.
[38] R. Robinson,et al. Depression following Myocardial Infarction , 1992, International journal of psychiatry in medicine.
[39] E. Braunwald,et al. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.
[40] H. White,et al. Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy , 1993 .
[41] R. Califf,et al. Scorecard Cardiovascular Medicine: Its Impact and Future Directions , 1994, Annals of Internal Medicine.
[42] E. Topol,et al. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. , 1987, The American journal of cardiology.
[43] K. Lee,et al. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. , 1990, The American journal of cardiology.
[44] E. Braunwald,et al. Comparison of Clinical Outcomes for Women and Men after Acute Myocardial Infarction , 1994, Annals of Internal Medicine.
[45] M. Simoons,et al. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute. , 1987, The American journal of cardiology.
[46] K. Wegscheider,et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.
[47] J. Boissel,et al. Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. , 1990, European heart journal.
[48] R. Califf,et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1993, Journal of the American College of Cardiology.
[49] R. Califf,et al. Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? , 1996, American heart journal.
[50] J. Alpert,et al. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. , 1990, American heart journal.
[51] K. Lee,et al. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. , 1995, The American journal of cardiology.
[52] C. Viscoli,et al. Differences between women and men in survival after myocardial infarction. Biology or methodology , 1990 .
[53] R. Califf,et al. Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. , 1995, The American journal of cardiology.
[54] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[55] G. Tognoni,et al. The GISSI Study: further analysis. Italian Group for the Study of Streptokinase in Myocardial Infarction (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico, GISSI). , 1987, Circulation.
[56] A. Jaffe,et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. , 1988, Journal of the American College of Cardiology.